The biology and clinical relevance of the PTEN tumor suppressor pathwaySANSAL, Isabelle; SELLERS, William R.Journal of clinical oncology. 2004, Vol 22, Num 14, pp 2954-2963, issn 0732-183X, 10 p.Article

From integrated genomics to tumor lineage dependencyGARRAWAY, Levi A; SELLERS, William R.Cancer research (Baltimore). 2006, Vol 66, Num 5, pp 2506-2508, issn 0008-5472, 3 p.Article

P13K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant CancersWEE, Susan; JAGANI, Zainab; XIAOQIN XIANG, Kay et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 10, pp 4286-4293, issn 0008-5472, 8 p.Article

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitorsMELLINGHOFF, Ingo K; WANG, Maria Y; RIGGS, Bridget L et al.The New England journal of medicine. 2005, Vol 353, Num 19, pp 2012-2024, issn 0028-4793, 13 p.Article

Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesisKORKMAZ, Ceren G; KORKMAZ, Kemal S; MANOLA, Judith et al.The Journal of urology. 2004, Vol 172, Num 3, pp 1134-1139, issn 0022-5347, 6 p.Article

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityBARRETINA, Jordi; CAPONIGRO, Giordano; REDDY, Anupama et al.Nature (London). 2012, Vol 483, Num 7391, pp 603-607, issn 0028-0836, 5 p.Article

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapyBARRETINA, Jordi; TAYLOR, Barry S; CHIANG, Derek Y et al.Nature genetics. 2010, Vol 42, Num 8, pp 715-721, issn 1061-4036, 7 p.Article

Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the KidneyBEROUKHIM, Rameen; BRUNET, Jean-Philippe; SELLERS, William R et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 11, pp 4674-4681, issn 0008-5472, 8 p.Article

An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arraysXIAOJUN ZHAO; CHENG LI; GRAY, Joe W et al.Cancer research (Baltimore). 2004, Vol 64, Num 9, pp 3060-3071, issn 0008-5472, 12 p.Article

dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity dataMING LIN; WEI, Lee-Jen; SELLERS, William R et al.Bioinformatics (Oxford. Print). 2004, Vol 20, Num 8, pp 1233-1240, issn 1367-4803, 8 p.Article

Modeling Genomic Diversity and Tumor Dependency in Malignant MelanomaLIN, William M; BAKER, Alissa C; HODI, F. Stephen et al.Cancer research (Baltimore). 2008, Vol 68, Num 3, pp 664-673, issn 0008-5472, 10 p.Article

BRAF mutation predicts sensitivity to MEK inhibitionSOLIT, David B; GARRAWAY, Levi A; GOLUB, Todd R et al.Nature (London). 2006, Vol 439, Num 7074, pp 358-362, issn 0028-0836, 5 p.Article

Akt-regulated pathways in prostate cancerMAJUMDER, Pradip K; SELLERS, William R.Oncogene (Basingstoke). 2005, Vol 24, Num 50, pp 7465-7474, issn 0950-9232, 10 p.Article

Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemiaBENTIRES-ALJ, Mohamed; PAEZ, J. Guillermo; RICHARDS, William G et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 8816-8820, issn 0008-5472, 5 p.Article

Growth factor receptor tyrosine kinase inhibitors; clinical development and potential for prostate cancer therapy. DiscussionBLACKLEDGE, George; SELLERS, William R; SMITH, Matthew R et al.The Journal of urology. 2003, Vol 170, Num 6, pp S77-S83, issn 0022-5347, 2Conference Paper

Clinical use of monoclonal antibody HuJ591 therapy: Targeting prostate specific membrane antigen. DiscussionNANUS, David M; MILOWSKY, Matthew I; KANTOFF, Philip W et al.The Journal of urology. 2003, Vol 170, Num 6, pp S84-S89, issn 0022-5347, 2Conference Paper

The evolving role of chemotherapy and other systemic therapies for managing localized prostate cancer. DiscussionOH, William K; ROACH, Mack III; SMITH, Matthew R et al.The Journal of urology. 2003, Vol 170, Num 6, pp S28-S34, issn 0022-5347, 2Conference Paper

Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAF_II250 kinase activitySIEGERT, Jennifer L; RUSHTON, John J; SELLERS, William R et al.Oncogene (Basingstoke). 2000, Vol 19, Num 50, pp 5703-5711, issn 0950-9232Article

A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer PatientsTIEDT, Ralph; DEGENKOLBE, Elisa; BLANK, Jutta et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 15, pp 5255-5264, issn 0008-5472, 10 p.Article

An Oncogenic Role for ETV1 in MelanomaJANE-VALBUENA, Judit; WIDLUND, Hans R; HAHN, William C et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 5, pp 2075-2084, issn 0008-5472, 10 p.Article

COT drives resistance to RAF inhibition through MAP kinase pathway reactivationJOHANNESSEN, Cory M; BOEHM, Jesse S; CAPONIGRO, Giordano et al.Nature (London). 2010, Vol 468, Num 7326, pp 968-972, issn 0028-0836, 5 p.Article

A 2-Mb critical region implicated in the microcephaly associated with terminal 1q deletion syndromeHILL, Anthony D; CHANG, Bernard S; HILL, R. Sean et al.American journal of medical genetics. Part A. 2007, Vol 143, Num 15, pp 1692-1698, issn 1552-4825, 7 p.Article

A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-α SignalingGAITHER, Alex; PORTER, Dale; RAMSEY, Tim et al.Cancer research (Baltimore). 2007, Vol 67, Num 24, pp 11493-11498, issn 0008-5472, 6 p.Article

Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysisXIAOJUN ZHAO; WEIR, Barbara A; SUGARBAKER, David et al.Cancer research (Baltimore). 2005, Vol 65, Num 13, pp 5561-5570, issn 0008-5472, 10 p.Article

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cellsBERGER, Raanan; FEBBO, Phillip G; GOLUB, Todd R et al.Cancer research (Baltimore). 2004, Vol 64, Num 24, pp 8867-8875, issn 0008-5472, 9 p.Article